In RA patients, intraarticular glucocorticoids are associated not only with clinical improvement, but also decreased synovial expression of COX1 and 2 and mPGES1, as well as decreased PGE2 production (44, 55). The gene discussed is PTGES; the disease is rheumatoid arthritis.